MCC
SRPT icon

Money Concepts Capital’s Sarepta Therapeutics SRPT Stock Holding History

Money Concepts Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,021
Closed -$1.53M – 454
2025
Q1 		$1.53M Sell
24,021
-168
-0.7% -$17.7K 0.11% 171
2024
Q4 		$2.94M Sell
24,189
-1,679
-6% -$206K 0.22% 104
2024
Q3 		$3.23M Sell
25,868
-1,155
-4% -$160K 0.25% 91
2024
Q2 		$4.27M Sell
27,023
-407
-1% -$52.3K 0.36% 66
2024
Q1 		$3.55M Buy
27,430
+32
+0.1% +$3.92K 0.33% 82
2023
Q4 		$2.64M Sell
27,398
-342
-1% -$32.8K 0.25% 108
2023
Q3 		$3.36M Buy
27,740
+572
+2% +$64.7K 0.35% 84
2023
Q2 		$3.11M Sell
27,168
-443
-2% -$57.1K 0.32% 96
2023
Q1 		$3.81M Sell
27,611
-787
-3% -$102K 0.21% 94
2022
Q4 		$3.68M Sell
28,398
-8,156
-22% -$945K 0.16% 126
2022
Q3 		$4.04M Buy
36,554
+239
+0.7% +$24.1K 0.24% 82
2022
Q2 		$2.75M Sell
36,315
-112
-0.3% -$8.24K 0.24% 91
2022
Q1 		$2.85M Buy
36,427
+1,936
+6% +$148K 0.16% 144
2021
Q4 		$3.11M Buy
+34,491
New +$2.95M 0.26% 96
2021
Q1 		$2.78M Buy
37,274
+6,344
+21% +$585K 0.22% 103
2020
Q4 		$5.27M Buy
+30,930
New +$4.58M 0.49% 54

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Money Concepts Capital's SRPT Position: Q2 2025 in Review

Money Concepts Capital sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 24,021 shares — an estimated $1.53M sold.

Money Concepts Capital first reported a position in SRPT in Q4 2020 and held it in 16 quarters. The position peaked at $5.27M in Q4 2020. 362 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Money Concepts Capital reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Money Concepts Capital sold 24,021 Sarepta Therapeutics shares in Q2 2025, an estimated $1.53M.
  • Money Concepts Capital first reported a position in Sarepta Therapeutics in Q4 2020 and held it in 16 quarters.
  • Money Concepts Capital's Sarepta Therapeutics position peaked at $5.27M in Q4 2020.
  • 362 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Money Concepts Capital's 13F filing for Q2 2025, filed 14 Aug 2025.